Skip to main content

Peer Review reports

From: Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001–2010

Original Submission
14 Aug 2013 Submitted Original manuscript
25 Sep 2013 Reviewed Reviewer Report - Philip Buck
7 Oct 2013 Reviewed Reviewer Report - Roberto Cappellani
14 Oct 2013 Reviewed Reviewer Report - Steven Hass
2 Dec 2013 Author responded Author comments - MerriKay Oleen-Burkey
Resubmission - Version 2
2 Dec 2013 Submitted Manuscript version 2
2 Dec 2013 Author responded Author comments - MerriKay Oleen-Burkey
15 Dec 2013 Reviewed Reviewer Report - Philip Buck
Resubmission - Version 3
2 Dec 2013 Submitted Manuscript version 3
Publishing
9 Jan 2014 Editorially accepted
14 Jan 2014 Article published 10.1186/1471-2377-14-11

You can find further information about peer review here.

Back to article page